Incretin-based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta-analysis of observational studies.
Samuel IgweokpalaNaheemot Olaoluwa SuleAntonios DourosOriana H Y YuKristian B FilionPublished in: Diabetes, obesity & metabolism (2023)
This study suggests that the use of incretin-based drugs is not associated with the risk of diabetic retinopathy among individuals with type 2 diabetes. However, these findings should be interpreted with caution considering the limited quality of some of the available evidence.